Literature DB >> 9287293

Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles.

L P Choo-Smith1, W Garzon-Rodriguez, C G Glabe, W K Surewicz.   

Abstract

The interaction of Alzheimer's Abeta peptide and its fluorescent analogue with membrane vesicles was studied by spectrofluorometry, Congo Red binding, and electron microscopy. The peptide binds selectively to the membranes containing gangliosides with a binding affinity ranging from 10(-6) to 10(-7) M depending on the type of ganglioside sugar moiety. This interaction appears to be ganglioside-specific as under our experimental conditions (neutral pH, physiologically relevant ionic strength), no Abeta binding was observed to ganglioside-free membranes containing zwitterionic or acidic phospholipids. Importantly, the addition of ganglioside-containing vesicles to the peptide solution dramatically accelerates the rate of fibril formation as compared with that of the peptide alone. The present results strongly suggest that the membrane-bound form of the peptide may act as a specific "template" (seed) that catalyzes the fibrillogenesis process in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287293     DOI: 10.1074/jbc.272.37.22987

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

Review 1.  Cholesterol, lipid rafts, and disease.

Authors:  Kai Simons; Robert Ehehalt
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

2.  Effect of sterols on beta-amyloid peptide (AbetaP 1-40) channel formation and their properties in planar lipid membranes.

Authors:  Silvia Micelli; Daniela Meleleo; Vittorio Picciarelli; Enrico Gallucci
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

3.  The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption.

Authors:  Justin Legleiter; John D Fryer; David M Holtzman; Andtomasz Kowalewski
Journal:  ACS Chem Neurosci       Date:  2011-10-19       Impact factor: 4.418

4.  A yeast toxic mutant of HET-s((218-289)) prion displays alternative intermediates of amyloidogenesis.

Authors:  Karine Berthelot; Sophie Lecomte; Julie Géan; Françoise Immel; Christophe Cullin
Journal:  Biophys J       Date:  2010-08-09       Impact factor: 4.033

5.  Membrane localization of beta-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization.

Authors:  Rui-Qin Liu; Qing-Hua Zhou; Shang-Rong Ji; Qiang Zhou; Du Feng; Yi Wu; Sen-Fang Sui
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

Review 6.  Fluorescence spectroscopy of protein oligomerization in membranes.

Authors:  Galyna P Gorbenko
Journal:  J Fluoresc       Date:  2010-04-06       Impact factor: 2.217

7.  Cytoplasmic domain of human myelin protein zero likely folded as beta-structure in compact myelin.

Authors:  Xiaoyang Luo; Deepak Sharma; Hideyo Inouye; Daniel Lee; Robin L Avila; Mario Salmona; Daniel A Kirschner
Journal:  Biophys J       Date:  2006-12-01       Impact factor: 4.033

8.  Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13.

Authors:  Mike P Williamson; Yu Suzuki; Nathan T Bourne; Tetsuo Asakura
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

Review 9.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 10.  Cell death and survival through the endoplasmic reticulum-mitochondrial axis.

Authors:  R Bravo-Sagua; A E Rodriguez; J Kuzmicic; T Gutierrez; C Lopez-Crisosto; C Quiroga; J Díaz-Elizondo; M Chiong; T G Gillette; B A Rothermel; S Lavandero
Journal:  Curr Mol Med       Date:  2013-02       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.